| Dr Donald A Cadogan, PHD | |
|
134 S Encinitas Ave, Monrovia, CA 91016-2830 | |
| (626) 303-8861 | |
| Not Available |
| Full Name | Dr Donald A Cadogan |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 134 S Encinitas Ave, Monrovia, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144382649 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY12583 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Donald A Cadogan, PHD 134 S Encinitas Ave, Monrovia, CA 91016-2830 Ph: (626) 303-8861 | Dr Donald A Cadogan, PHD 134 S Encinitas Ave, Monrovia, CA 91016-2830 Ph: (626) 303-8861 |
News Archive
On March 22, during the 41st Annual Meeting & Exhibition of the American Association for Dental Research (AADR), held in conjunction with the 36th Annual Meeting of the Canadian Association for Dental Research, a symposium titled "Building the Oral Health Care Workforce: Multipronged Research on Dental Therapy" will take place to help attendees understand opportunities for effective utilization of new workforce models in nontraditional settings within the oral health care community.
A new study by researchers from the London School of Hygiene and Tropical Medicine, Cambridge University and the Karolinska Institute in Sweden has found that even light or moderate intensity physical activity, such as walking or cycling, can substantially reduced the risk of early death.
Kolltan Pharmaceuticals, a privately held biopharmaceutical company, today announced treatment of the first cancer patient with Kolltan's lead drug candidate, KTN3379, as part of a Phase 1 clinical study evaluating safety, preliminary evidence of antitumor activity, and pharmacokinetics. KTN3379 is a human monoclonal antibody that blocks the activity of ErbB3, a member of the ErbB family of receptor tyrosine kinases.
During Feeding Tube Awareness Week (FTAW), 2-8 February, ausEE Inc. is putting the spotlight on tube feeding and the day-to-day impact on individuals, carers and families.
The World Health Organization announced that they have established a new limit for indoor radon gas. The new maximum radon level is 2.7. This is a 32% reduction from the previously accepted "action level" of 4.0. http://www.mitigationsystem.com/releases/release/7166404/19723.htm
› Verified 4 days ago
Odette Felix, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1829 8th Ave, Monrovia, CA 91016 Phone: 480-242-5889 | |
Benjamin Zequeira-russell, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 140 E Colorado Blvd Ste D, Monrovia, CA 91016 Phone: 626-358-1564 | |
Dr. Elizabeth Pinghwa Chang, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 902 S Myrtle Ave, Monrovia, CA 91016 Phone: 626-216-5915 | |
Anthony Cecere, Psychologist Medicare: Accepting Medicare Assignments Practice Location: 521 1/2 S Myrtle Ave Ste 9&10, Monrovia, CA 91016 Phone: 818-806-9566 | |
Dr. Pablo David Anabalon, LICENSEDPSYCHOLOGIST Psychologist Medicare: Not Enrolled in Medicare Practice Location: 902 S Myrtle Ave, Monrovia, CA 91016 Phone: 626-357-3258 | |
Dr. Carolyn Ford, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 305 W Duarte Rd Unit F, Monrovia, CA 91016 Phone: 708-261-5378 |